Books ## (look for used copies or go to university library)

Molecular Biology of the Cell (If you can only purchase one book, get this one.)

DNA Methylation and Complex Human Disease (Translational Epigenetics)

Ankylosing Spondylitis In Clinical Practice

Ankylosing Spondylitis and the Spondyloarthropathies

Ankylosing Spondylitis and Klebsiella

Ankylosing Spondylitis

Rheumatoid Arthritis


Spondyloarthritis: new insights into clinical aspects, translational immunology and therapeutics.

Metabolic syndrome, autoimmunity and rheumatic diseases.

Genetics of immune-mediated inflammatory diseases.

Fatigue in ankylosing spondylitis is associated with the brain networks of sensory salience and attention.

Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.


The ramifications of HLA-B27

Role of HLA-B27 in the pathogenesis of ankylosing spondylitis

HLA-B27 Misfolding and Ankylosing Spondylitis

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats

An update on the genetics of HLA-B27 associated acute anterior uveitis

Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27

HLA-B*27 subtypes and their implications in the pathogenesis of ankylosing spondylitis.

Intestinal flora

Evidence of the Immune Relevance of Prevotella copri, a Gut Microbe, in Patients With Rheumatoid Arthritis

Periodontal Pathogens are Likely to be Responsible for the Development of Ankylosing Spondylitis

Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella

Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall–King Hypothesis

Gut Microbiome of the Canadian Arctic Inuit

The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates.

Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages.

Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis.

Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals.

Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response.

Microbiota Composition and the Integration of Exogenous and Endogenous Signals in Reactive Nasal Inflammation.

These few are regarding livestock...not humans, but they are interesting none-the-less

High-grain diets altered rumen fermentation and epithelial bacterial community and resulted in rumen epithelial injuries of goats.

Diet-induced inflammation: From gut to metabolic organs and the consequences for the health and longevity of ruminants.

Gut/Brain axis (not all links here are specific to AS, but important info)

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition.

Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.

Influence of gut microbiota on neuropsychiatric disorders.

The Role of Microbiota in Depression - a brief review.

Neurotransmitter modulation by the gut microbiota.

Gastrointestinal hormones and the dialogue between gut and brain.

Crosstalk Between Gut Microbiota and the Central Nervous System: A Focus for Alzheimer's Disease.

Relevance of gutmicrobiota in cognition, behaviour and Alzheimer's disease.

Making Sense of… the Microbiome in Psychiatry.

The gut microbiota: A new target in the management of alcohol dependence?

Centrally Acting Agents for Obesity: Past, Present, and Future.

Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function.


Increased intestinal permeability in ankylosing spondylitis.

Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis.

Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?

Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives.

Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Molecular basis for intestinal mucin recognition by galectin-3 and C-type lectins

Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease.

Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.

immune system biochemistry

Immune cells involved in the pathogenesis of ankylosing spondylitis.

Role of innate immune system in the pathogenesis of ankylosing spondylitis.

Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies

Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population

Genetically determined high activities of the TNF-alpha, IL23/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis.

Th1 and Th2 responses: what are they?

Role of IL-32 Gamma on Bone Metabolism in Autoimmune Arthritis.

Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis.

High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation.

Identification of pathways significantly associated with spondyloarthropathy/ankylosing spondylitis using the sub‑pathway method.

Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.

Regulation of Osteoclast Differentiation by Cytokine Networks


Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis

Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of Structural damage in the spine over two years in patients with ankyLosing spondylitis

New treatment paradigms in spondyloarthritis.

Cannabinoids as novel anti-inflammatory drugs

Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model.

because it's a neat read

Ankylosing spondylitis in the pharaohs of ancient Egypt.

View the RAW markdown.